1. Home
  2. MCBS vs COLL Comparison

MCBS vs COLL Comparison

Compare MCBS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$35.00

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$22.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
COLL
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
MCBS
COLL
Price
$35.00
$22.60
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$33.00
$51.40
AVG Volume (30 Days)
51.6K
806.6K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
3.63%
N/A
EPS Growth
4.76
N/A
EPS
1.53
N/A
Revenue
N/A
$780,567,000.00
Revenue This Year
$36.78
$8.01
Revenue Next Year
$2.44
N/A
P/E Ratio
$22.78
N/A
Revenue Growth
N/A
23.62
52 Week Low
$24.53
$21.65
52 Week High
$37.46
$50.79

Technical Indicators

Market Signals
Indicator
MCBS
COLL
Relative Strength Index (RSI) 42.78 28.57
Support Level $34.58 N/A
Resistance Level $35.30 $35.33
Average True Range (ATR) 0.68 0.88
MACD -0.04 0.13
Stochastic Oscillator 30.68 26.24

Price Performance

Historical Comparison
MCBS
COLL

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: